MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Molecular Breast Imaging
- First Posted Date
- 2013-03-07
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT01806558
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase 2
Completed
- Conditions
- Untreated Adult Acute Myeloid Leukemia
- Interventions
- Drug: CytarabineDrug: Daunorubicin HydrochlorideOther: Laboratory Biomarker AnalysisDrug: NilotinibOther: Pharmacological Study
- First Posted Date
- 2013-03-07
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 34
- Registration Number
- NCT01806571
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Leptin Biology in Adipose Tissue
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Other: obesity
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2016-11-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 5
- Registration Number
- NCT01800864
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: SalineDrug: HyperglycemiaOther: ExerciseProcedure: Blood DrawsOther: Fasting procedure
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2014-05-12
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT01800370
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Feasibility Study for a Web Based Health Coaching Program
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Behavioral: Web Based Health Coaching
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT01797510
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide
Phase 2
Completed
- Conditions
- Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
- Interventions
- First Posted Date
- 2013-02-18
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 9
- Registration Number
- NCT01794039
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
RCT of the Double Wire Technique for Sphincterotomy
Not Applicable
Terminated
- Conditions
- Cholangiopancreatography, Endoscopic RetrogradeSphincterotomy, EndoscopicVATER'S AMPULLA
- Interventions
- Procedure: Transpancreatic sphincterotomy
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 16
- Registration Number
- NCT01792466
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy
Early Phase 1
Completed
- Conditions
- Stage IV Skin Melanoma
- Interventions
- Other: Laboratory Biomarker AnalysisProcedure: Radionuclide ImagingBiological: Technetium Tc 99 Hydrazinonicotinamide-Tricine-linked Interleukin-2
- First Posted Date
- 2013-02-12
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 5
- Registration Number
- NCT01789827
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Procalcitonin Use in Pneumonia Patients in the Critical Care Setting
Not Applicable
Completed
- Conditions
- Pneumonia
- Interventions
- Other: Use of procalcitonin as biomarker to guide therapy
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 134
- Registration Number
- NCT01788488
- Locations
- 🇺🇸
Mayo Clinic Health System Eau Claire, Eau Claire, Wisconsin, United States
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Not Applicable
Recruiting
- Conditions
- Enteropathy-Associated T-Cell LymphomaMediastinal (Thymic) Large B-Cell LymphomaAnaplastic Large Cell LymphomaChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaRefractory Anaplastic Large Cell LymphomaAggressive Non-Hodgkin LymphomaAngioimmunoblastic T-Cell LymphomaHepatosplenic T-Cell LymphomaNasal Type Extranodal NK/T-Cell Lymphoma
- Interventions
- Dietary Supplement: CholecalciferolOther: Laboratory Biomarker Analysis
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 500
- Registration Number
- NCT01787409
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
© Copyright 2025. All Rights Reserved by MedPath